Home > National Drug Code (NDC) > Reese ONETAB Congestion and cough

Reese ONETAB Congestion and cough - 10956-814-01 - (Guaifenesin/phenylephrine)

Alphabetical Index


Drug Information of Reese ONETAB Congestion and cough

Product NDC: 10956-814
Proprietary Name: Reese ONETAB Congestion and cough
Non Proprietary Name: Guaifenesin/phenylephrine
Active Ingredient(s): 400; 10    mg/1; mg/1 & nbsp;   Guaifenesin/phenylephrine
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Reese ONETAB Congestion and cough

Product NDC: 10956-814
Labeler Name: Reese Pharmaceutical Co
Product Type: HUMAN OTC DRUG
FDA Application Number: part341
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20100601

Package Information of Reese ONETAB Congestion and cough

Package NDC: 10956-814-01
Package Description: 1 BOTTLE, PLASTIC in 1 CARTON (10956-814-01) > 30 TABLET in 1 BOTTLE, PLASTIC (10956-814-30)

NDC Information of Reese ONETAB Congestion and cough

NDC Code 10956-814-01
Proprietary Name Reese ONETAB Congestion and cough
Package Description 1 BOTTLE, PLASTIC in 1 CARTON (10956-814-01) > 30 TABLET in 1 BOTTLE, PLASTIC (10956-814-30)
Product NDC 10956-814
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Guaifenesin/phenylephrine
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20100601
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Reese Pharmaceutical Co
Substance Name GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Strength Number 400; 10
Strength Unit mg/1; mg/1
Pharmaceutical Classes

Complete Information of Reese ONETAB Congestion and cough


General Information